戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 er co-morbidities (but high refusal in rural clinics).
2 ed to intervention (5 clinics) or control (5 clinics).
3 ill help to interpret CNVs identified in the clinic.
4 of the field to get better and faster to the clinic.
5 ical therapies upon their translation to the clinic.
6 ed vitrectomies at the Geneva University Eye Clinic.
7 ism to introduce modified FcgammaRs into the clinic.
8 tic approach potentially translatable to the clinic.
9 le inhibitors now under investigation in the clinic.
10 ations in medicine that are now entering the clinic.
11 x, 26 +/- 1), enrolled at a gastroenterology clinic.
12 ementation questions frequently faced in the clinic.
13 ervasive form of programed cell death in the clinic.
14 ard the elimination of HIV reservoirs in the clinic.
15 white race and increased distance to the eye clinic.
16 everal vaccine formulations currently in the clinic.
17 d that patients visit our outpatient allergy clinic.
18  133 patients visited our outpatient allergy clinic.
19 sensitivity profiles before treatment in the clinic.
20 acyclines could be quickly translated to the clinic.
21  the translation of novel therapies into the clinic.
22 e defects repair is still challenging in the clinic.
23 scans on SDOCT images acquired in a glaucoma clinic.
24 cal for successful implementation within the clinic.
25  including 52% of patients visiting the OPAT clinic.
26 SARS-CoV-2-RBD nanoparticle vaccine into the clinic.
27 ogenicity to enable rapid translation to the clinic.
28 adults would be sufficient to advance to the clinic.
29  thus have proven difficult to target in the clinic.
30 ibitory concentrations in the lab and in the clinic.
31 ests a context for advancing MEKi use in the clinic.
32 ing cancer-immune phenotypes observed in the clinic.
33 ed testing of direct NLRP3 inhibitors in the clinic.
34 nical models and more limited results in the clinic.
35  with greater satisfaction with provider and clinic.
36 an that frequently quoted to patients in the clinic.
37  for magnetic resonance imaging (MRI) in the clinic.
38 tively or negatively influence cancer in the clinic.
39 eases with the potential to translate to the clinic.
40 ive-medicine potential of these cells in the clinic.
41 nd advancement of DUB-targeting drugs to the clinic.
42 transition of engineered solid organs to the clinic.
43  and applications in basic biology or in the clinic.
44 ot followed in subspecialty gastroenterology clinics.
45 epartment/urgent care centers and outpatient clinics.
46 t Study (HOPS) participants in care at 9 HIV clinics.
47  regulations for independent pain-management clinics.
48 lth Sciences Chiang Mai and combined Bangkok clinics.
49 ecruited 305 patients from two diabetic foot clinics.
50 en limited to individual, specialty-specific clinics.
51 cted have been widely reported or brought to clinics.
52 er time at the Duke Eye Center and satellite clinics.
53 the community level, both for recipients and clinics.
54 aneous immunotherapy (EPIT) currently in the clinics.
55 viding more oversight to outpatient oncology clinics.
56  trained practitioners in specialist allergy clinics.
57  delivered by health coaches embedded in the clinics.
58 miluminescence immunoassay in cardiovascular clinics.
59 adults enrolled during 2001-2014 at HIV care clinics.
60 cally confirmed, were recruited from allergy clinics.
61 included 7 tertiary care neuro-ophthalmology clinics.
62 crucial for advancing a vaccine candidate to clinics.
63  in the community and in different specialty clinics.
64 as an efficient test for low-cost rollout to clinics.
65 nagement, and precision medicine in diabetes clinics.
66 attending 2 posttransplant skin surveillance clinics: 1 in London, UK and 1 in Philadelphia, USA.
67 ents undergoing AF ablation at the Cleveland Clinic (2011-2018) were enrolled in a prospectively main
68 ring hospital admission, 21.7% in ambulatory clinics, 3.2% in emergency units, and only 0.5% in urgen
69 t these 3 private practice retinal specialty clinics, 41% of after-hours appointment requests resulte
70  Fourteen (45%) of 31 detainees with care at clinic A had colonization.
71          All were among oncology patients at clinic A.
72 d controlled trial was done at 13 specialist clinics, academic centres, and hospitals in the USA.
73 6,261 unique patients presenting to surgical clinics across five hospitals from July 1 to December 31
74  35 participants with Parkinson's disease in-clinic and 25 participants monitored at home.
75 s a variant of these peptides that is in the clinic and can be considered as a novel therapy in coron
76 at our Inflammatory Bowel Disease outpatient clinic and compare with adult-onset UC.
77 ential to improve diagnostic accuracy in the clinic and facilitate research studies including enrollm
78  immune deficiencies is being brought to the clinic and hopefully will provide safe and effective the
79 transmission linkages were from the same OAT clinic and involved spousal or common-law partnerships.
80 K cell cytotoxicity can be approached in the clinic and laboratory for the discovery of novel gene va
81 istance, 180 clinical isolates from the Mayo Clinic and Mayo Clinic Laboratories not characterized fo
82  randomly allocated clusters (a primary care clinic and neighbouring TFH facilities) 1:1, stratified
83 he study was conducted in an established CBT clinic and the chief investigator is the originator of M
84 andard behavioral measurements in the lab or clinic and the large-scale, high frequency assessments n
85 ide patient-centered care in both safety net clinics and community settings may narrow the gaps in ac
86 e/eye/feet) in public and private outpatient clinics and diabetes centers in Hong Kong.
87 as been a remarkable rise of cardio-oncology clinics and service lines.
88  first antenatal visit at one of the 7 study clinics and were >=18 years old at delivery were eligibl
89 d significantly from 49 to 27 (P<0.001, Mayo Clinic) and from 30 to 16 (P<0.001; Australia).
90 ohorts from 49/70 to 39/70 (56%; P=0.1; Mayo Clinic) and from 30/54 to 20/54 (37%; P=0.1; Australia).
91 be decreased at the societal, health system, clinic, and individual levels.
92 isease burden, its current management in the clinic, and where the knowledge gaps remain.
93  experimental standards at the bench, in the clinic, and within the community must prioritize adequat
94  registered for HIV care at one of the trial clinics, and either starting or already on ART.
95 iated with any financial cost of travel to a clinic (aOR 0.86 [0.83-0.88], p<0.0001), increased child
96                                              Clinics are continuing to monitor and adapt their appoin
97                        Dedicated transgender clinics are planned to provide comprehensive care, inclu
98 nation after brain death (DBD) SLK from Mayo Clinic Arizona and Mayo Clinic Minnesota were reviewed.
99 CD LT performed at Mayo Clinic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Rochester from 1999 to 2
100 g and refills (hybrid approach); or standard clinic ART initiation and refills.
101 econdary analysis, clinicians' diagnoses, in-clinic assessments, and investigational-assay results we
102 over traditional neurologist administered in-clinic assessments.
103 ries receive specimens from approximately 60 clinics associated with the Gonococcal Isolate Surveilla
104  drops were recruited from the ophthalmology clinic at the National University Hospital of Singapore.
105  were recruited from pediatric ophthalmology clinics at Great Ormond Street Hospital and Moorfields E
106  (N = 3308) was recruited from prenatal care clinics at the Instituto Nacional Materno Perinatal (INM
107 ecutive babies who presented to immunisation clinics at the primary health-care centres, whose mother
108  than 9 months who presented to immunisation clinics at these five centres, using an ELISA-based poin
109 few randomized controlled trials have tested clinic-based alcohol interventions.
110 ly increased viral suppression compared with clinic-based ART, particularly among men, eliminating di
111  to provide adherence support or to standard clinic-based care in Dar es Salaam and Lusaka.
112 use mortality by 28%, compared with standard clinic-based care.
113 groups of research volunteers: hospital- and clinic-based cohorts are enriched for FTLD-TDP cases, wh
114 against 10 ophthalmologists in a prospective clinic-based dataset with 510 outpatients newly enrolled
115  by subgroup was moderate for multicomponent clinic-based interventions but was low or very low for o
116      Assay performance was evaluated in four clinic-based prospective cohorts.
117      We assessed 1717 adults linked to study clinics before rapid ART introduction and 800 after rapi
118                                   Lastly, as clinics begin to re-open for routine appointments, proto
119 (2-FDG) with PET is undeniably useful in the clinic, being able, among other uses, to monitor change
120 l Dutch sexually transmitted infection (STI) clinics between 2008 and 2017 were used (N = 271 242 con
121                                      At each clinic, between May 19 and October 27, 2016, a systemati
122 ONClinicalTrials.gov NCT04338360.FUNDINGMayo Clinic, Biomedical Advanced Research and Development Aut
123     We demonstrate MixEHR on MIMIC-III, Mayo Clinic Bipolar Disorder, and Quebec Congenital Heart Dis
124 conferred a small incremental advantage over clinic BP in predicting cardiovascular/renal events, whi
125 dded value of 24-h BP phenotypes compared to clinic BP in predicting the subsequent fatal and non-fat
126 dney outcomes, and mortality, independent of clinic BP.
127 tive of long-term cardiovascular events than clinic BP.
128 s prevalence was not due to clonal spread in clinic but rather to an intermingling of distinct commun
129 ns important in exercise training and in the clinic, but its conceptual basis should now be understoo
130 s to clear infection, have advanced into the clinic, but the field is still in its infancy.
131 he attrition of novel analgesic drugs in the clinic can be attributed in the main to two factors: fai
132 e delivery resources to form an ICU survivor clinic care process and compare this new process to post
133 , including head circumference and Cleveland Clinic (CC) score, which is a semiquantitative surrogate
134  Mayo Clinic K2R Research Pipeline, and Mayo Clinic Center for Individualized Medicine.
135 r, recent observations in the laboratory and clinic challenge central tenets of the current paradigm
136 e services, patient monitoring services) and clinic characteristics (eg, types of providers, availabi
137                              Demographic and clinic characteristics of the participants, response to
138              Using a database of unique Mayo Clinic CICU admissions from 2007 to 2018, we identified
139 ings, and two were delivered in primary care clinics; clinical setting was not reported in 17 studies
140 ve PLWH in the Vanderbilt Comprehensive Care Clinic cohort initiating INSTI-, protease inhibitor (PI)
141 nrolled individuals from three clinics (the 'clinic cohort').
142 we analyzed 116,400 patient records from our clinic collected over a 24-year period and found that st
143 ) in 7 nurse-led, public-sector primary care clinics-combined into 6 clusters-over 8 steps and 19 mon
144     Simplified personalized dosimetry in the clinic continues to be challenging.
145  Universitario de Malaga (HRUM) and Hospital Clinic de Barcelona (HCB) were prospectively included an
146     Health care personnel (HCP) at Cleveland Clinic diagnosed with COVID-19, who recovered without ne
147 ral practice clinics were enrolled, but four clinics dropped out shortly after randomisation.
148 rgeting the CHK1 kinase are advancing in the clinic, drug resistance is rapidly emerging.
149 ing of women attending a high-risk pregnancy clinic during the recent ZIKV outbreak in Brazil.
150  history of trauma who attended the headache clinic during the same period.
151                                          The clinic efficiency and cost savings achieved by eliminati
152 gency department (ED) visits, and outpatient clinic encounters before age 1 were compared between gro
153 ollment in HIV care, starting 9 months after clinic enrollment.
154 ders referred to a recurrent fever disorders clinic established in an Allergy/Immunology division at
155 University of California San Francisco, Mayo Clinic Florida, and University of Toronto).
156                 All DCD LT performed at Mayo Clinic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Roc
157 red with 1064 patients assigned to physician clinic follow-up (79%, P<0.001).
158 entions to prevent readmissions through OPAT clinic follow-up and to further assess factors associate
159 was used to assess OPAT and other outpatient clinic follow-up in conjunction with age, sex, pathogen,
160 s through mobile vans; ART initiation at the clinic followed by mobile van monitoring and refills (hy
161 ic, and reliable analysis of bacteria in the clinic, food, and environment.
162 up times to a retina rather than a nonretina clinic for 52 of 151 patients who showed no pathologic f
163 25-year-old woman was referred to our breast clinic for assessment of a palpable mass in her left bre
164 therapeutic agents have been utilized in the clinic for cancer treatment, low patient response rates
165     Genome editing is-or will soon be-in the clinic for several diseases, with more applications unde
166 ib and vandetanib, have been explored in the clinic for tumors with activating RET gene alterations w
167 whether the Targeting Effective Analgesia in Clinics for HIV (TEACH) intervention improves guideline-
168 y settings, seven were delivered in military clinics for veterans or active military personnel, five
169 f complex machine learning algorithms in the clinic, for each patient with CLL, CLL-TIM provides expl
170 d 1219 patients attending satellite dialysis clinics found that older age was a risk factor for infec
171 cancer with a mini-invasive approach at Mayo Clinic from 2005 to 2018.
172 od to detect disease susceptibility loci for clinic genomic data.
173 ncreased viral suppression compared with the clinic group (306 [74%] vs 269 [63%], RR 1.18, 95% CI 1.
174 ided follow-up (48%) compared with physician clinic-guided follow-up (77%, P<0.001).
175 r, translation of MS-based proteomics to the clinic has been hampered by its complexity and the subst
176 us of attempts to establish tolerance in the clinic, highlighting the dynamic online discussion surro
177 ts who sought treatment emergently and after clinic hours from 3 academic nonhospital-associated reti
178 vated IOP that may not be apparent during in-clinic hours, requiring more detailed clinical phenotypi
179 r adoption of a multidisciplinary telehealth clinic in a post-pandemic world.
180 mary care facility and a referral colposcopy clinic in Cape Town, South Africa.
181 rgeted application it could be of use in the clinic in conjunction with an appropriate targeted seque
182 nrolled at a sexually transmitted infections clinic in Lilongwe, Malawi.
183                     Medecins Sans Frontieres clinic in Mumbai, India has been providing concomitant B
184  medical records review at a safety-net PrEP clinic in Seattle, Washington, and found that barriers t
185 patients were enrolled from 32 hospitals and clinics in Australia, Belgium, Canada, France, Germany,
186 =38 degrees C) at presentation to outpatient clinics in Dar es Salaam, Tanzania.
187  pragmatic trial at three primary healthcare clinics in Johannesburg, South Africa.
188 phylaxis (PrEP) in maternal and child health clinics in Kenya.
189 improve patient outcomes in moderately sized clinics in South Africa.
190 ontrolled trial was conducted in infertility clinics in Tehran, Iran.
191 ith patient-reported outcomes from eight HIV clinics in the United States, which from April 2016-Marc
192 study of children with MS/CIS followed at 12 clinics in the US Network of Pediatric MS Centers, who r
193 adults tested for TB across 4 primary health clinics in urban Uganda (between May 2018 and December 2
194  obesity treatment delivered in primary care clinics in which a high percentage of the patients were
195 -eligible adults newly linking to care at 64 clinics in Zambia between 1 April 2014 and 31 July 2015.
196 of patients lost to follow up (LTFU) from 32 clinics in Zambia to understand the reasons for silent t
197 vitation to a sexual and reproductive health clinic, in which all methods of contraception are availa
198 ctive, observational study in 7 primary care clinics, in which an intervention comprised of clinician
199 ncrease the use of genetics in heart failure clinics, increased availability of genetic counsellors a
200 dependently after accounting for a recent in-clinic IOP measured by Goldmann applanation tonometry.
201  experimental stroke, but translation to the clinic is impeded by the large doses needed.
202          However, translation of MSOT to the clinic is still in its preliminary stages.
203 S cohort, from brain banks based at the Mayo Clinic (Jacksonville, FL, USA) and in Munich (Germany),
204  National Comprehensive Cancer Network, Mayo Clinic K2R Research Pipeline, and Mayo Clinic Center for
205 nical isolates from the Mayo Clinic and Mayo Clinic Laboratories not characterized for specific resis
206  additional samples were submitted from Mayo Clinic Laboratories reference clients, with positive res
207    In highly resource-limited settings, many clinics lack same-day microbiological testing for active
208  models evaluating different combinations of clinic-level factors, enhanced adherence services (aHR,
209 dvanced HCC and 156 whole exome of Barcelona Clinic Liver Cancer (BCLC) 0/A were analyzed by whole-ex
210 ology of hepatitis B, the stage of Barcelona Clinic Liver Cancer (BCLC) B and C, and the presence of
211  guidelines, and caution about unscrupulous 'clinics' marketing unproven therapies to patients.
212 sistance, which often goes undetected in the clinic, may allow for bacterial survival and establishme
213  this novel SARS-CoV-2 T-cell therapy to the clinic), membrane, spike, and nucleocapsid peptides elic
214  (DBD) SLK from Mayo Clinic Arizona and Mayo Clinic Minnesota were reviewed.
215 and potential for rapid advancement into the clinic, monoclonal antibodies (mAbs) represent a highly
216                        Pioneered by the Mayo Clinic, multimodal therapy with neoadjuvant chemoradioth
217 ); Nutrition, Metabolism and Atherosclerosis Clinic (n=552); and UK Biobank cohorts (n=306).
218 andard CQI tools flexibly, tailored to local clinic needs.
219  of capsular contracture were assessed using clinic notes and independent graders reviewing two-dimen
220 January 2018, patients seen in the ED and GI clinic of Loghman Hakim Hospital with unexplained abdomi
221        Patients attending the HIV outpatient clinic of Pathophysiology Department at <<Laiko>> Genera
222 Patients who visited the Pericardial Disease Clinic of Samsung Medical Center with an (18)FDG-PET/CT
223  old or younger, seen in neuro-ophthalmology clinics of the international ODDS (Optic Disc Drusen Stu
224 C (HRV C), the most frequent subtypes in the clinics of various pulmonary diseases.
225                   We collected data from the clinic on diagnoses of celiac disease based on duodenal
226 uration of treatment and its regimen (in the clinic or home-based), its cost-effectiveness and long-t
227 undergo future implant placement in the same clinic or with the same professional was recorded, and a
228 0 clinics were randomized to intervention (5 clinics) or control (5 clinics).
229 s Eakins' remarkable masterpiece, "The Agnew Clinic." Osler had been on the faculty of the University
230                          In standard-of-care clinics, participants received treatment in accordance w
231 itive results were reported for 9 (17%) Mayo Clinic patient samples, with 6 interpreted as likely con
232 -risk (89.3% v 85.7%; P = .712) and oncology clinic patients (96.6% v 96.6%; P = 1.000), although MSI
233                               Among 354 Mayo Clinic patients with NASH cirrhosis, 253 (71%) had diabe
234 sponse for MDD patients enrolled in the Mayo Clinic PGRN-AMPS SSRI trial.
235 ngle-arm trial was done across 25 outpatient clinics, primarily at academic medical centres, in Austr
236 yopia Treatment Study (ATS) and the authors' clinic protocol.
237 ffect sizes with time-step fixed effects and clinic random effects (Model 1).
238 clinical data and investigational use in the clinic, relatively few drugs targeting nucleic acid sens
239                                   Outpatient clinics represent the key point of entry for timely acce
240  a computerized registry and statewide liver clinics resulting in higher linkage to care (86%) than n
241 linic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Rochester from 1999 to 2019 were included (N = 71
242   We examined the 10-year experience of Mayo Clinic's kidney paired donation (KPD).We aimed to determ
243 tinopathy screening system in a primary care clinic serving a low-income metropolitan patient populat
244 8 years) hospitalized with SAB at three Mayo Clinic sites between January 2015 and March 2017.
245  of febrile Kenyan children at five hospital/clinic sites from January 2014 to December 2017.
246  oral iron were recruited from 30 outpatient clinic sites in the United States into 2 identically des
247   We evaluated POC implementation in varying clinic sizes (10-50 patient initiating ART per month).
248 d too costly to be purchased by every health clinic, so fundus cameras are an inconvenient tool for w
249         Despite arising only recently in the clinic, ST313 L3 is a phylogenetic intermediate between
250                              In intervention clinics, study nurses assessed participants on the basis
251                                            A clinic survey captured information on care delivery (eg,
252  and results comparable to those found by in-clinic testing.
253 ducted at 91 US urology and medical oncology clinics that enrolled 478 men aged 50 to 80 years with b
254 rospectively enrolled individuals from three clinics (the 'clinic cohort').
255 nt treatment and prevention paradigms in the clinic, there is an increasing push for personalized the
256 rested in early feeding (28.2%), and lack of clinic time (20.9%).
257  number of nodules biopsied with FNA in this clinic to determine if the use of ACR TI-RADS would have
258 n from an urban sexually transmitted disease clinic to determine if there were differences in microRN
259 mors and has the potential to be used in the clinic to improve treatment of patients.
260 osome formulations are currently used in the clinic to reduce the side effects and improve the pharma
261 eutic device suitable for use outside of the clinic to suppress tics and PU in TS.
262                      We randomly assigned 18 clinics to provide patients with either an intensive lif
263  the first installation in a private medical clinic took place in 1900.
264 e in-home (enrolled siblings) and outpatient clinic transmission.
265                            Combined protocol clinics treated children using 2 sachets of ready-to-use
266                                Standard care clinics treated SAM with weight-based RUTF rations, and
267 ms, four were conducted in specialist trauma clinics, two were delivered in home settings, and two we
268 alls to a random selection of US urgent care clinics (UCCs) to describe the proportion that offer mem
269 or dropping out of care in an urban HIV care clinic using electronic medical records and geospatial d
270 nitoring, 2 VF assessments were performed in clinic using standard automated perimetry (4 tests total
271 oss to follow-up [LTFU; >180 days late for a clinic visit at closure of the database]) using Cox prop
272 nrolled 306 patients, 290 of whom attended a clinic visit during the study period: 145 were sent the
273    From immediately preceding the cardiology clinic visit to 30 days after, 49.0% in the intervention
274 with, and retention in, adult clinical care (clinic visit within the previous 6 months).
275 difficult to complete an early postdischarge clinic visit, especially during the current pandemic.
276 ays before, and 24 hours before a cardiology clinic visit.
277 T with a dolutegravir-based regimen at first clinic visit.
278 at intervention hospitals attended a COMPASS clinic visit.
279 m Satisfaction with Life Scale (SWLS) in the clinic visit.
280                         Among 548 female STI clinic visitors 16-24 years old who provided an anal swa
281 planned calls (P = 0.009), and had unplanned clinic visits (P = 0.003).
282 ge of having clear, frank discussions during clinic visits about treatment cost and perceived value.
283         The direct annual cost of ambulatory clinic visits alone for chronic symptomatic FBDs is appr
284 up visits scheduled to coincide with routine clinic visits at 6 and 12 months.
285                         Overall frequency of clinic visits during the first 7 days postdischarge was
286  COVID-19 deaths associated with vaccination clinic visits, especially for the vaccinated children.
287 d vision symptom severity scores measured at clinic visits.
288 ded the cost-effectiveness threshold for all clinic volumes.
289  CRP test regime to detect flare outside the clinic was also assessed.
290                  Adding RFP to community eye clinics was associated with an increased odds of referra
291 nic prescribing records of the remaining 109 clinics, we identified 13 657 eligible patients who were
292          Adults presenting at a Cape Town TB clinic were enrolled.
293 17, and March 21, 2019, 113 general practice clinics were enrolled, but four clinics dropped out shor
294 urgery, physical medicine and rehabilitation clinics were evaluated.
295 jection fraction from 34 Dutch outpatient HF clinics were included.
296 design (ClinicalTrials.gov: NCT02776254), 10 clinics were randomized to intervention (5 clinics) or c
297  a tertiary hospital rheumatology outpatient clinic with clinical suspicion of inflammatory sacroilii
298 te translation of epigenetic analyses to the clinic, with a particular focus on methods to profile ge
299 brain stimulation, and gene therapy into the clinic within the next decade or so.
300 tegration for routine medical decisions into clinic workflow.

 
Page Top